http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008038119-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b11286864531f1b2992f0e7234d54f01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b9187cb59933459d97254f292157fa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91daf4a485d9d882e301e536cf710b72
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L5-15
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-0522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-155
filingDate 2007-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45fcbdab38474dd13dd27e08e87095ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43eaea83f3082e60c811f7b31333ff44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13a878e7e3f89824de370ec889b72c7f
publicationDate 2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008038119-A3
titleOfInvention A composition comprising a coenzyme q10 - cyclodextrin - complex and a carotene and use thereof for the treatment of pathologic states of e.g. the central nervous system
abstract A composition comprising: (a) a complex of coenzyme QlO and at least one cyclodextrin; and (b) at least one carotene; and use thereof for the treatment of various diseases, in particular of neurodegenerative diseases of the central nervous system, particularly of Parkinson's disease (PD).
priorityDate 2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7030102-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004011423-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1681053-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281915

Total number of triples: 35.